Cancer-related Cognitive Impairment Clinical Trial
Official title:
Pilot Study of Photobiomodulation for Cancer-Related Cognitive Impairment
This is a single site, pilot randomized, double blinded control trial designed to assess changes in cognitive symptoms in cancer survivors with cancer-related cognitive impairment. Patients will be randomized into one of two Arms: Intervention or Control. - Arm A: Intervention Group: Use of the THOR LED Photobiomodulation helmet 3x per week for 6 weeks. Helmet will be in 'therapeutic setting', 35mW/cm2 = 42J/cm2 - Arm B: Control Group: Use of the THOR LED Photobiomodulation helmet 3x per week for 6 weeks. Helmet will be in 'placebo setting', 0mW/cm2 = 0J/cm2 This study has been designed to assess the hypothesis that Photobiomodulation can have a positive impact on cognitive symptoms in cancer survivors with cancer-related cognitive impairment. 30 participants will be recruited for this study, 15 per group. Self-report questionnaires assessing cognitive concerns, cognitive abilities, quality of life, depression, and anxiety will be administered at three timepoints through the study Baseline, End of Study Visit and 1 Month Follow Up
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05030792 -
An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04565769 -
Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors
|
||
| Recruiting |
NCT05186948 -
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
|
||
| Recruiting |
NCT02661308 -
Reducing Cancer Side-effects With Systematic Light Exposure
|
N/A | |
| Completed |
NCT03452436 -
Testosterone, Cognition, Ageing, and Cancer
|
||
| Completed |
NCT04667689 -
An Online Cognitive Assessment in Cancer Patients
|
N/A |